AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIOGEN INC. Director's Dealing 2023

Apr 25, 2023

30291_dirs_2023-04-25_811c3ff2-b9ef-44b5-ae13-6d6c65fe33ac.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2023-04-17

Reporting Person: Keeney Adam (Head of Corporate Development)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct